H.R. 10531: Sickle Cell Disease Treatment Centers Act of 2026
This bill would create a new federal grant program to set up and support Sickle Cell Disease Treatment Centers around the country. The centers would use a hub-and-spoke model, meaning a main medical center would coordinate care with smaller connected providers such as clinics, primary care practices, infusion centers, and federally qualified health centers.
What the program is for
The bill is aimed at improving care for people with sickle cell disease and other inherited blood disorders called heritable hemoglobinopathies. It would try to make care more coordinated over a patient’s lifetime, improve the transition from pediatric to adult care, and expand access to specialty treatment and support services.
How the treatment centers would work
To qualify for funding, a network would need to include:
- a medical hub such as a hospital, clinic, or university health center;
- at least one spoke, such as a local clinic, primary care provider, infusion center, or other health care provider;
- at least one community-based nonprofit organization; and
- a community health worker as part of the care team.
The hub would be responsible for coordinating care, following treatment guidelines, training providers, and managing specialty services. The spokes would help provide direct care, primary care, telehealth, genetic counseling, and care plans, while working with the hub and community organizations.
What grant money could pay for
Grant funds could be used for a range of activities, including:
- operating the hub-and-spoke network;
- training health care providers on sickle cell treatment;
- providing coordinated care, pain management, mental health services, and genetic counseling;
- telehealth services;
- programs to help patients move from pediatric to adult care;
- social work and community health worker services;
- data collection and quality improvement;
- helping patients access health insurance and understand their coverage rights;
- support for transportation or travel costs when patients need in-person care; and
- testing and genetic counseling related to sickle cell trait.
National coordination and data collection
The bill would also create or designate a National Sickle Cell Disease Coordinating Center. That center would help coordinate the treatment centers, advise the Secretary of Health and Human Services, develop a national strategy, support providers and patients, and help spread best practices.
In addition, the CDC would be directed to collect and share data on sickle cell disease, including patient outcomes, complications, prevalence, geographic distribution, and factors that affect health outcomes. The bill also calls for public education and outreach about sickle cell disease and sickle cell trait.
Where the grants would go
The Secretary would be directed to award grants with attention to areas where sickle cell disease is more common, and to try to fund centers across the country so more patients can access care. The bill says priority may go to applicants that include historically Black colleges and universities or minority-serving institutions, serve high-prevalence areas, or serve rural communities.
Oversight and reporting
The bill would require the Health and Human Services Secretary to publish a request for information within 180 days of enactment and before each new grant cycle. It would also require reports to Congress 3 years after enactment and every 5 years after that on how the program is affecting patient outcomes, who is being served, and what activities are being funded.
Funding
The bill would authorize whatever sums are necessary starting in fiscal year 2027. Of the money appropriated each year, the bill says:
- 70% may go to hub-and-spoke networks;
- 20% may go to community-based organizations;
- 5% may go to the national coordinating center; and
- 5% may go to CDC data collection activities.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
3 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Sep. 24, 2026 | Introduced in House |
| Sep. 24, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.